Highlights Bloomios, Inc.

Equities

BLMS

US0948571098

Delayed OTC Markets Other stock markets 07:00:00 28/05/2024 pm IST			5-day change	1st Jan Change
0.0009 ^USD	-18.18%		+50.00%	-70.00%

15/04	Involuntary Petition Filed Against Bloomios, Inc.	CI
08/03	Bloomios, Inc. Ceases Manufacturing At the Facility and Terminated All Employees	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Bloomios, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/23/21	CI
Bloomios, Inc. Provides Revenue Guidance for the Second Quarter of 2023	02/23/02	CI
Bloomios, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
Bloomios, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
Bloomios, Inc. acquired Infusionz, LLC from Upexi, Inc. for $23.5 million.	27/22/27	CI
Bloomios, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	23/22/23	CI
Bloomios, Inc. to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and Other Natural Ingredients	05/22/05	CI
Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022	18/22/18	CI
Bloomios, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Earnings Flash (BLMS) BLOOMIOS Posts Q4 Revenue $1.7M	19/22/19	MT
Bloomios, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	16/22/16	CI
Bloomios, Inc. Announces Selection as the Exclusive Cannabidiol Product Manufacturer for DRYWORLD	01/22/01	CI
Bloomios, Inc. Provides Earnings Guidance for the Year 2021	17/21/17	CI
Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Bloomios, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	19/21/19	CI
Bloomios, Inc. Reports Consolidated Earnings Results for the Full Year Ended December 31, 2020	21/21/21	CI
XLR Medical Corp. completed the acquisition of CBD Brand Partners, LLC from Mammoth Crest Capital, LLC.	12/21/12	CI
XLR Medical Corp. entered into a non-binding letter of intent to acquire CBD Brand Partners, LLC from Mammoth Crest Capital, LLC.	09/21/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bloomios, Inc.

Equities

BLMS

US0948571098

Highlights

Filters